Presentation to include clinical data from Aronora's phase 2 study of AB002, a first-in-class protein C activator enzyme that is being developed for the treatment and prevention of thrombotic and inflammatory diseases.
Read MoreThe Brazil animal diagnostics market is expected to hit USD 287 million by 2027, owing to the rising number of companion animal ownership and increasing prevalence of infectious & parasitic diseases across the country.
Read MoreAsia Pacific apheresis equipment market revenue surpassed USD 606 million in 2018 and is set to achieve significant CAGR from 2019 to 2025, driven by increasing incidence of blood related disorders in emerging economies.
Read MoreThis clinical trials-related webinar will provide background on heavy menstrual bleeding (HMB) and discuss HMB trials from the PI and patient perspectives
Read MoreAnaheim, CA 9/16/2011 - Dr. Daniel Jae Kim, along with the outstanding oncologists and hematologists from The Oncology Institute of Hope and Innovation, are celebrating 14 months of success at their Anaheim center.
Read MoreThe Oncology Institute of Hope and Innovation, the leader in providing state-of-the-art medical care and comprehensive cancer treatment recently announced the opening of it's new Anaheim facility and the appointment of three new physicians.
Read More